Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients-Reference-Cited by-同舟云学术

Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients

Published:1990-05 Issue:1 Volume:75 Page:4-9
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Visani G.,Finelli C.,Castelli U.,Petti M. C.,Ricci P.,Vianelli N.,Gianni L.,Zuffa E.,Aloe Spiriti M. A.,Latagliata R.,Pileri S.,Magrini U.,Gugliotta L.,Morra E.,Bernasconi C.,Mandelli F.,Tura S.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.1990.tb02609.x/fullpdf

Reference22 articles.

1. MYELOFIBROSIS CLINICAL, HEMATOLOGIC AND PATHOLOGIC STUDY OF 110 PATIENTS

2. Chronic myelocytic leukemia versus idiopathic myelofibrosis.A diagnostic problem in bone marrow biopsies

3. Working classification of chronic myeloproliferative disorders based on histological, haematological, and clinical findings.

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloproliferative Neoplasms: Contemporary Review and Molecular Landscape;International Journal of Molecular Sciences;2023-12-12

2. Therapeutic Results and Survival of Patients with Myelofibrosis Treated with Ruxolitinib—A Real-Life Longitudinal Study;Cancers;2023-10-20

3. Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT;The Lancet Haematology;2023-01

4. Thrombocytopenia in Patients With Myelofibrosis: Pathogenesis, Prevalence, Prognostic Impact, and Treatment;Clinical Lymphoma Myeloma and Leukemia;2022-07

5. Momelotinib for the treatment of myelofibrosis with anemia;Future Oncology;2022-06